IXIJEVRO Trademark

Trademark Overview

On Wednesday, October 24, 2007, a trademark application was filed for IXIJEVRO with the United States Patent and Trademark Office. The USPTO has given the IXIJEVRO trademark a serial number of 79046289. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, October 24, 2017. This trademark is owned by NOVARTIS AG. The IXIJEVRO trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines and adjuvants for vaccines
ixijevro

General Information

Serial Number79046289
Word MarkIXIJEVRO
Filing DateWednesday, October 24, 2007
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, October 24, 2017
Registration Number3472644
Registration DateTuesday, July 22, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 6, 2008

Trademark Statements

Goods and ServicesVaccines and adjuvants for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 27, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxosmithkline Biologicals S.A.
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressBE
Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH-4002 Basel
CH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH-4002 Basel
CH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH-4002 Basel
CH

Trademark Events

Event DateEvent Description
Friday, May 18, 2018NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, May 18, 2018DEATH OF INTERNATIONAL REGISTRATION
Friday, January 22, 2016TOTAL INVALIDATION PROCESSED BY THE IB
Monday, December 28, 2015TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, December 22, 2015INVALIDATION PROCESSED
Tuesday, October 27, 2015TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, July 3, 2015CHANGE OF OWNER RECEIVED FROM IB
Friday, February 27, 2015CANCELLED SECTION 71
Sunday, April 28, 2013NEW REPRESENTATIVE AT IB RECEIVED
Thursday, May 7, 2009NEW REPRESENTATIVE AT IB RECEIVED
Friday, December 26, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, November 14, 2008FINAL DISPOSITION NOTICE SENT TO IB
Friday, November 14, 2008FINAL DISPOSITION PROCESSED
Thursday, October 23, 2008FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 22, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, May 6, 2008PUBLISHED FOR OPPOSITION
Wednesday, April 16, 2008NOTICE OF PUBLICATION
Friday, March 28, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, March 28, 2008ASSIGNED TO LIE
Saturday, March 15, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 15, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, March 15, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, March 15, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 7, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 7, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 8, 2008REFUSAL PROCESSED BY IB
Wednesday, January 9, 2008NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, January 9, 2008REFUSAL PROCESSED BY MPU
Wednesday, January 9, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, January 8, 2008NON-FINAL ACTION WRITTEN
Friday, January 4, 2008ASSIGNED TO EXAMINER
Friday, December 14, 2007NEW APPLICATION ENTERED IN TRAM
Thursday, December 13, 2007SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

ixijevro vaccines adjuvants